标题
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
作者
关键词
-
出版物
Cancers
Volume 10, Issue 8, Pages 271
出版商
MDPI AG
发表日期
2018-08-15
DOI
10.3390/cancers10080271
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
- (2018) Michael B. Streiff et al. AMERICAN JOURNAL OF HEMATOLOGY
- Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
- (2018) Chatree Chai-Adisaksopha et al. AMERICAN JOURNAL OF MEDICINE
- Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119)
- (2018) L. Tittl et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
- (2018) Ang Li et al. THROMBOSIS RESEARCH
- Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
- (2017) Hakeam A. Hakeam et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low Molecular Weight Heparins as Extended Prophylaxis Against Recurrent Thrombosis in Cancer Patients
- (2017) Cocav A. Engman et al. Journal of the National Comprehensive Cancer Network
- Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study
- (2016) Simon Mantha et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Direct Oral Anticoagulants in Patients With VTE and Cancer
- (2015) Maria Cristina Vedovati et al. CHEST
- Recurrence of Venous Thromboembolism in Patients With Cancer Treated With Warfarin
- (2015) Ariela L. Marshall et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
- (2015) Michael B. Streiff et al. Journal of the National Comprehensive Cancer Network
- Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis
- (2015) S. Schulman et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
- (2014) N. van Es et al. BLOOD
- Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis
- (2014) Ryma Ihaddadene et al. THROMBOSIS RESEARCH
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies
- (2013) Jay Desai et al. THROMBOSIS AND HAEMOSTASIS
- Antithrombotic Therapy for VTE Disease
- (2012) Clive Kearon et al. CHEST
- Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier
- (2012) F. CAMPIGOTTO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2012) D. FARGE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism
- (2011) S. Parpia et al. Contemporary Clinical Trials
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
- (2009) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started